Imprimis Spins Off Eton Pharmaceuticals To Challenge Pricey Pipelines Of Mallinckrodt, Endo
June 20, 2017 at 16:05 PM EDT
In response to a call for heightened drug competition by FDA Commissioner Scott Gottlieb, Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) ...
